Serum S100B: A possible biomarker for severity of obstructive sleep apnea
Conclusion Serum S100B protein was significantly elevated in OSA patients and its serum levels correlated with the severity of the disease. Increased serum S100B could indicat brain injury and could be a potential serum biomarker for detection of early neurological complications in OSA patients that could improve the management and care of these patients.
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research
More News: Brain | Egypt Health | Neurology | Obstructive Sleep Apnea | Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study | Tuberculosis